Beijing Hotgen Biotech (688068.SS) Earnings Analysis
Beijing Hotgen Biotech (688068.SS) has no confirmed upcoming earnings date. Trailing P/E -46.75.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 688068.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 688068.SS. This page updates as the calendar is published.
688068.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-25 | -0.77 CNY | n/a | n/a | n/a |
| 2025-12-31 | -0.92184 CNY | n/a | n/a | n/a |
| 2025-09-29 | -0.28099 CNY | n/a | n/a | n/a |
| 2025-05-21 | -1.4714 CNY | n/a | n/a | n/a |
| 2025-03-31 | -0.26 CNY | n/a | n/a | n/a |
688068.SS valuation and analyst view
| Trailing P/E | -46.75 |
|---|---|
| Trailing EPS | -2.94264 CNY |
| Price / book | 4.52 |
| Dividend yield | 0.00% |
| Market cap | 11.43B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Beijing Hotgen Biotech (688068.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 688068.SS. This page updates as the calendar is published.
Did 688068.SS beat earnings last quarter?
Consensus estimate data was not available for 688068.SS's 2026-04-25 report.
What is 688068.SS's current P/E ratio and EPS?
688068.SS trades at a trailing P/E of -46.75 on trailing EPS of -2.9426382347258064 CNY.
What do analysts rate 688068.SS?
688068.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.